{"title":"Obstructive sleep apnea and ambulatory blood pressure abnormalities in children with chronic kidney disease.","authors":"Suryendru Kumar, Abhishek Goyal, Mahendra Atlani, Shikha Malik, Abhijit Pakhare, Mahesh Maheshwari, Amber Kumar, Rupesh Raina, Girish Chandra Bhatt","doi":"10.1097/MBP.0000000000000642","DOIUrl":"https://doi.org/10.1097/MBP.0000000000000642","url":null,"abstract":"<p><strong>Background: </strong>Obstructive sleep apnea (OSA) and hypertension are common complications in children with chronic kidney disease (CKD). Progression of CKD can aggravate OSA and hypertension whereas worsening sleep apnea can make hypertension difficult to treat in CKD patients. We, therefore, conducted a prospective study to evaluate the association between OSA and hypertension in pediatric patients with CKD.</p><p><strong>Method: </strong>In this prospective observational study consecutive children with CKD stage 3-5 (nondialysis dependent) underwent overnight polysomnography and 24-h ambulatory blood pressure monitoring (ABPM). The detailed clinical features and investigations were recorded in a prestructured performa.</p><p><strong>Results: </strong>Twenty-two children completed overnight polysomnography and 24-h ABPM was performed within 48 h of performing polysomnography. The median (IQR) age of the study population was 11 (8.5-15.5) years, with an age range of 5-18 years. Moderate-severe OSA defined as apnea-hypopnea index (AHI ≥5) was seen in 14 (63.6%) children, periodic limb movement syndrome in 20 (91%) and poor sleep efficacy in 9 (40.9%) children. Ambulatory blood pressure was abnormal in 15 (68.2%) children with CKD. Of them, 4 (18.2%) had ambulatory hypertension, 9 (40.9%) had severe ambulatory hypertension and 2 (9.1%) had masked hypertension. A statistically significant correlation of sleep efficiency with nighttime DBP SD score/Z score (SDS/Z) (r = -0.47; P = 0.02); estimated glomerular filtration rate with SBP loads (r = -0.61; P < 0.012); DBP loads (r = -0.63; P < ) and BMI with SBP load (r = 0.46; P = 0.012) was found.</p><p><strong>Conclusion: </strong>Our preliminary findings suggest that ambulatory blood pressure abnormalities, OSA, periodic limb movement syndrome and poor sleep efficiency are highly prevalent in children with CKD stages 3-5.</p>","PeriodicalId":8950,"journal":{"name":"Blood Pressure Monitoring","volume":"28 3","pages":"129-133"},"PeriodicalIF":1.3,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9425831","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Bruce S Alpert, Paul Matsumura, Colin O Wu, Bruce Friedman, Doris Flotzinger, David Osborn
{"title":"Statistical considerations for testing automated sphygmomanometers in special patient populations.","authors":"Bruce S Alpert, Paul Matsumura, Colin O Wu, Bruce Friedman, Doris Flotzinger, David Osborn","doi":"10.1097/MBP.0000000000000644","DOIUrl":"https://doi.org/10.1097/MBP.0000000000000644","url":null,"abstract":"<p><p>The International Standards Organization 81060-2:2018 is the current global Standard for the validation of automated sphygmomanometers. It specifies the requirements for clinical studies on the general population, as well as additional requirements for special populations, which might have physiologic characteristics that affect the accuracy of blood pressure measurements. This paper summarizes the statistical methodology behind the sample size required to test automated sphygmomanometers in these special populations and specifically addresses the pregnant patient population.</p>","PeriodicalId":8950,"journal":{"name":"Blood Pressure Monitoring","volume":"28 3","pages":"167-170"},"PeriodicalIF":1.3,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9456499","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jing Li, Li-Hong Han, Ru Feng, Li-Hao Wu, Jie Cai, Tian-Ying Zeng, Hui Liu, Ya-Wen Zeng, Li Zhou, Zhong-Qun Zhan
{"title":"Validation of the JAMR F1701T (arm type) pressure monitor according to the Association for the Advancement of Medical Instrumentation/European Society of Hypertension/ISO 81060-2:2018 protocol.","authors":"Jing Li, Li-Hong Han, Ru Feng, Li-Hao Wu, Jie Cai, Tian-Ying Zeng, Hui Liu, Ya-Wen Zeng, Li Zhou, Zhong-Qun Zhan","doi":"10.1097/MBP.0000000000000643","DOIUrl":"https://doi.org/10.1097/MBP.0000000000000643","url":null,"abstract":"<p><p>To validate the JAMR F1701T (arm type) blood pressure (BP) monitor according to the Association for the Advancement of Medical Instrumentation/European Society of Hypertension/International Organization for Standardization (AAMI/ESH/ISO) Universal Standard (ISO 81060-2:2018). A total of 90 subjects (male 60 and female 30) were recruited to fulfill the criteria of the AAMI/ESH/ISO Universal Standard (the number, gender, age, limber size, and BP distribution), and sequential measurements of BP, including both SBP and DBP were obtained using the test device and the standard mercury sphygmomanometer. A total of 270 sets of comparison data (three sets of each subject) were obtained and analyzed. According to the validation criterion 1 of ISO 81060-2:2018, the mean ± SD of the differences between the JAMR F1701T and mercury sphygmomanometer BP (systolic/diastolic) readings was 2.06 ± 6.83/-4.84 ± 5.23 mmHg. For criterion 2, the SD of the averaged BP (systolic/diastolic) differences between the JAMR F1701 and reference BP (systolic/diastolic) per participant was 5.62/4.39 mmHg (the requirement was ≤6.43/5.01 mmHg by calculation). The JAMR F1701T met all the requirements of the ISO 81060-2:2018, and can be recommended for clinical and self/home use.</p>","PeriodicalId":8950,"journal":{"name":"Blood Pressure Monitoring","volume":"28 3","pages":"163-166"},"PeriodicalIF":1.3,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/6c/d2/bpmj-28-163.PMC10132453.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9456503","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Investigation of effective invasive blood pressure control methods to prevent acute exacerbation of acute aortic dissection.","authors":"Naoya Inoue, Ryo Ohinata, Takashi Mishina, Hiroki Kumihashi, Takehiro Hiramatsu, Takashi Ogane, Yohei Takayama, Shuji Morikawa","doi":"10.1097/MBP.0000000000000647","DOIUrl":"https://doi.org/10.1097/MBP.0000000000000647","url":null,"abstract":"<p><strong>Background: </strong>Acute aortic dissection is associated with high mortality and increased risk of complications. Acute exacerbations have a relatively high frequency; however, the contributing factors are unclear. Blood pressure (BP) and heart rate control are important factors, but the ideal BP control strategy to prevent acute exacerbations under invasive arterial pressure monitoring remains unclear. Therefore, in this study, we aimed to determine the relationship between invasive arterial BP and the effects of acute exacerbation of aortic dissection.</p><p><strong>Methods and results: </strong>This single-centre, retrospective, case-control study included 104 patients with a partial diagnosis of acute aortic dissection (Stanford type A or B) who were treated conservatively between September 2013 and September 2022. The patients were divided into exacerbation (acute exacerbation; n = 26) and stable (no acute deterioration) groups. The SBP trend (122.5 ± 13.1 vs. 116.6 ± 10.6 mmHg, respectively; P = 0.024) and mean BP trend (77.8 ± 5.8 vs. 74.4 ± 7.5 mmHg, respectively; P = 0.038) significantly differed between the two groups. The time to target BP was significantly longer in the exacerbation group ( P = 0.036).</p><p><strong>Conclusion: </strong>The exacerbation group did not achieve a mean SBP < 120 mmHg. Moreover, the importance of early BP reduction was demonstrated in the present study.</p>","PeriodicalId":8950,"journal":{"name":"Blood Pressure Monitoring","volume":"28 3","pages":"123-128"},"PeriodicalIF":1.3,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9456988","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Linyi Li, Sen Bing, Kui Liu, Jun Jiang, Jieqiong Zhang, Changsheng Chen, Yi Wan
{"title":"Diagnostic accuracy of an oscillometric blood pressure monitor for atrial fibrillation screening.","authors":"Linyi Li, Sen Bing, Kui Liu, Jun Jiang, Jieqiong Zhang, Changsheng Chen, Yi Wan","doi":"10.1097/MBP.0000000000000645","DOIUrl":"https://doi.org/10.1097/MBP.0000000000000645","url":null,"abstract":"<p><strong>Objective: </strong>Atrial fibrillation is the most common arrhythmia of clinical significance and hypertension is one of its major risk factors. This study aimed to evaluate the diagnostic accuracy of an automated oscillometric blood pressure (BP) monitor with the function of atrial fibrillation detection for atrial fibrillation screening.</p><p><strong>Materials and methods: </strong>Patients attending outpatient cardiology clinics were recruited for atrial fibrillation screening by the BP monitor with triplicate BP measurements for atrial fibrillation detection. Furthermore, a single-lead ECG was recorded simultaneously for comparison as the reference standard. The diagnostic test's evaluation index were analyzed, including sensitivity, specificity, and receiver operator characteristic (ROC) analysis.</p><p><strong>Results: </strong>A total of 295 participants were analyzed including 166 males and 129 females, with an average age of 72.5 ± 5.9 years. The sensitivity and specificity for atrial fibrillation detection by the device were 1.000 and 0.904, respectively, with the area under the ROC curve of 0.952 (95% confidence interval: 0.929-0.975, P < 0.001). Furthermore, the device had a Kappa-value of 0.781 ( P < 0.001) with the single-lead ECG in detecting atrial fibrillation.</p><p><strong>Conclusion: </strong>The automated oscillometric BP monitor (G.LAB MD41A0) with atrial fibrillation detection function has high sensitivity and specificity with good accuracy for atrial fibrillation screening, which could be used as a reliable screening tool for the early detection of atrial fibrillation with potential benefits.</p>","PeriodicalId":8950,"journal":{"name":"Blood Pressure Monitoring","volume":"28 3","pages":"144-148"},"PeriodicalIF":1.3,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9456502","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Bernhard Roth, Tomas Lucca Bothe, Andreas Patzak, Niklas Pilz
{"title":"Validation of the ABPMpro ambulatory blood pressure monitor in the general population according to AAMI/ESH/ISO Universal Standard (ISO 81060-2:2018).","authors":"Bernhard Roth, Tomas Lucca Bothe, Andreas Patzak, Niklas Pilz","doi":"10.1097/MBP.0000000000000640","DOIUrl":"https://doi.org/10.1097/MBP.0000000000000640","url":null,"abstract":"<p><strong>Objective: </strong>The objective of this study is to evaluate the accuracy of the oscillometric upper-arm device ABPMpro (SOMNOmedics) for ambulatory blood pressure measurement in the general population according to the Association for the Advancement of Medical Instrumentation/European Society of Hypertension/International Organization for Standardization (AAMI/ESH/ISO) Universal Standard (ISO 81060-2:2018) at rest and during dynamic exercise.</p><p><strong>Methods: </strong>Subjects were recruited to fulfill the age, sex, blood pressure (BP) and cuff distribution criteria of the AAMI/ESH/ISO standard using the same arm sequential BP measurement method. Three appropriate cuff sizes (18-24, 24-34 and 34-46 cm) of the tested device were used for the arm-varying circumferences. The inflation and deflation measurement modes of the ABPMpro were investigated.</p><p><strong>Results: </strong>For the general validation study, 100 subjects were recruited and 90 were analyzed. For validation criterion (1), the mean ± SD of the differences between ABPMpro and reference BP was 0.7 ± 7.3/-0.7 ± 5.8 mmHg (systolic/diastolic) for inflation and 1.4 ± 7.7/-0.6 ± 6.1 mmHg for deflation measurements. For criterion (2), the SD of the averaged BP differences per subject was 5.98/5.10 mmHg for inflation and 6.46/5.36 mmHg for deflation measurements, thereby passing the threshold. In the ambulatory validation study ( N = 36), the mean difference was -1.2 ± 7.9/ 2.4 ± 6.6 mmHg for inflation and -0.7 ± 7.6/3.1 ± 7.0 mmHg for deflation measurements.</p><p><strong>Conclusion: </strong>The ABPMpro device fulfilled the ISO 81060-2:2018 requirements in the general population and in the ambulatory setting and can therefore be recommended for clinical use.</p>","PeriodicalId":8950,"journal":{"name":"Blood Pressure Monitoring","volume":"28 3","pages":"158-162"},"PeriodicalIF":1.3,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10132455/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9456501","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Blood Pressure MonitoringPub Date : 2023-04-01Epub Date: 2023-02-13DOI: 10.1097/MBP.0000000000000636
Bruce S Alpert
{"title":"Validation of the A&D UM-212BLE monitor according to ISO 81060-2, 2018: a device with clinically important programmability.","authors":"Bruce S Alpert","doi":"10.1097/MBP.0000000000000636","DOIUrl":"10.1097/MBP.0000000000000636","url":null,"abstract":"<p><strong>Objective: </strong>The objective of this report was to describe the validation of the A&D UM-212BLE automated oscillometric sphygmomanometer to the ISO 81060-2, 2018 protocol. The device is specifically designed for enhanced office and out-of-office programmability.</p><p><strong>Methods: </strong>A combined pediatric ( n = 35) and adult ( n = 50) population was studied at Clinmark LLC in Louisville, Colorado, USA. Same-arm sequential testing was performed following the ISO 81060-2, 2018 requirements. Five cuffs were tested with a total arm circumference range from 12 to 50 cm. Reference readings were done by two blinded observers performing simultaneous auscultation.</p><p><strong>Results: </strong>For validation of Criterion 1 the mean ± SD (mmHg) of the device minus the reference differences were 3.94 ± 6.89 for SBP and 2.09 ± 6.68 for DBP. Both passed the Standard limits for Criterion 2; the systolic(S)SD achieved was 5.56 (5.70 permitted) and the diastolic(D)SD was 6.01 (6.62 permitted). All other Standard requirements were met.</p><p><strong>Conclusions: </strong>The UM-212BLE passed all requirements. The features that make this device clinically superior include settings for automated office BP, variable pressure inflation, dual measurement modes (oscillometry, auscultation), the wide range of cuffs tested, automated irregular heartbeat detection, and full validation in a pediatric population. The inclusion of all of these features makes the UM-212BLE a highly attractive device for both office and out-of-office BP estimation.</p>","PeriodicalId":8950,"journal":{"name":"Blood Pressure Monitoring","volume":"28 2","pages":"113-115"},"PeriodicalIF":1.3,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/12/77/bpmj-28-113.PMC9981315.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9117219","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Blood Pressure MonitoringPub Date : 2023-04-01Epub Date: 2022-12-23DOI: 10.1097/MBP.0000000000000632
Ayberk Gorcan, Onur Argan, Eyup Avci, Tuncay Kiris, Ozgen Safak, Seda Tarik Yildirim, Elcim Yildirim, Halil Lutfi Kisacik, Hasan Kadi
{"title":"A new risk factor for predicting stroke in patients with atrial fibrillation: morning blood pressure surge.","authors":"Ayberk Gorcan, Onur Argan, Eyup Avci, Tuncay Kiris, Ozgen Safak, Seda Tarik Yildirim, Elcim Yildirim, Halil Lutfi Kisacik, Hasan Kadi","doi":"10.1097/MBP.0000000000000632","DOIUrl":"10.1097/MBP.0000000000000632","url":null,"abstract":"<p><strong>Background: </strong>Stroke, the most feared complication in patients with atrial fibrillation (AF), is still an important cause of mortality and morbidity. In our study, we aimed to investigate the frequency of stroke and related parameters in patients with atrial fibrillation, for whom 24-h ambulatory blood pressure monitoring (ABPM) was performed.</p><p><strong>Method: </strong>A total of 282 patients with permanent AF were included in this study. 24-h ABPM was performed in all patients. Morning blood pressure surge (MBPS) was defined as the difference between the mean SBP in the first 2 h after awakening and the lowest blood pressure (BP) at night. We evaluated parameters associated with stroke in patients with atrial fibrillation using univariate and multivariate Cox regression analysis.</p><p><strong>Result: </strong>Patients were followed for 19 ± 9.3 months and 22 ischemic strokes were detected during the follow-up period. Also, strokes were significantly lower in atrial fibrillation patients with a dipper BP pattern, whereas strokes were significantly higher in atrial fibrillation patients with a reverse-dipper BP pattern. In multivariate analysis, a history of hypertension ( P = 0.020), BP pattern ( P < 0.001) and MBPS ( P < 0.001) were found to be significantly related to stroke. MBPS levels >32.5 mmHg predicted stroke with a sensitivity of 77% and a specificity of 60% (AUC, 0.741; 95% CI, 0.647-0.834; P < 0.001).</p><p><strong>Conclusion: </strong>MBPS, BP pattern and presence of hypertension as an independent risk factor in predicting stroke in patients with atrial fibrillation. The reduction of the MBPS may be a new therapeutic target for preventing stroke.</p>","PeriodicalId":8950,"journal":{"name":"Blood Pressure Monitoring","volume":"28 2","pages":"73-78"},"PeriodicalIF":1.3,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9478973","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Blood Pressure MonitoringPub Date : 2023-04-01Epub Date: 2022-12-07DOI: 10.1097/MBP.0000000000000633
Michael Willis, Ghassan Darwiche, Martin Carlsson, Andreas Nilsson, Jonas Wohlin, Peter Lindgren
{"title":"Real-world long-term effects on blood pressure and other cardiovascular risk factors for patients in digital therapeutics.","authors":"Michael Willis, Ghassan Darwiche, Martin Carlsson, Andreas Nilsson, Jonas Wohlin, Peter Lindgren","doi":"10.1097/MBP.0000000000000633","DOIUrl":"10.1097/MBP.0000000000000633","url":null,"abstract":"<p><strong>Purpose: </strong>Hypertension is a leading causeof premature death worldwide and a major public health problem. This study investigated the long-term effects (>1 year) of digital hypertension monitoring by home blood pressure (HBP) measurements in combination with individualized remote treatment via a Swedish Digital Therapeutics platform in a large patient population.</p><p><strong>Methods: </strong>The primary endpoint, HBP, and exploratory endpoints, BMI, alcohol consumption, stress level, physical activity, and smoking, were assessed every 3 months for 540 and 360 days, respectively, in 7752 Swedish primary hypertension patients. Patients received individualized medical treatments and lifestyle advice via asynchronous text-based communication in an app. Changes from baseline in endpoints were calculated for the whole population and for subgroups defined by baseline SBP ≥135 (high SBP), 125-135 (suboptimal SBP), 115-125 (optimal SBP), and <115 mmHg (low SBP).</p><p><strong>Results: </strong>After 360 days of treatment, the whole population showed a significant increase of 57% (from 37 to 58%) in the proportion of patients with controlled SBP (i.e. SBP of 115-135 mmHg). The largest reduction in SBP of 13.8 mmHg was observed for the high SBP subgroup, whereas for the low SBP subgroup, SBP increased by 13.4 mmHg. BP improved most in the first three months, and for both the high and low BP subgroups, the improvement continued during the 540-day study period. Significant beneficial changes were also observed for some exploratory endpoints including BMI and smoking.</p><p><strong>Conclusions: </strong>In conclusion, the digital therapeutics platform was associated with significant improvement in BP control and associated risk factors, which were maintained over a longer period.</p>","PeriodicalId":8950,"journal":{"name":"Blood Pressure Monitoring","volume":"28 2","pages":"86-95"},"PeriodicalIF":1.3,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c1/24/bpmj-28-086.PMC9981322.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9478975","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Blood Pressure MonitoringPub Date : 2023-04-01Epub Date: 2023-03-01DOI: 10.1097/MBP.0000000000000635
{"title":"Device-guided slow breathing with direct biofeedback of pulse wave velocity - acute effects on pulse arrival time and self-measured blood pressure: Erratum.","authors":"","doi":"10.1097/MBP.0000000000000635","DOIUrl":"10.1097/MBP.0000000000000635","url":null,"abstract":"","PeriodicalId":8950,"journal":{"name":"Blood Pressure Monitoring","volume":"28 2","pages":"121"},"PeriodicalIF":1.2,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10473024/pdf/bpmj-28-121.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10529270","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}